High level of soluble tumor necrosis factor receptors is associated with lower residual diuresis volume in patients on hemodialysis: An exploratory study
PLOS One · 2025
DOI: 10.1371/journal.pone.0320019 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Gabriele Teixeira Gonçalves und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centro Integrado de Pós-Graduação e Pesquisa em Saúde (CIPq-Saúde), Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil. Hauptthemen laut MEDLINE: Renal Dialysis, Diuresis, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Patients on hemodialysis commonly present with elevated inflammatory markers. It is noteworthy, however, that higher levels of these markers may deteriorate residual renal function in in these individuals. Further investigation is essential to clarify the potential link between systemic chronic inflammatory parameters and residual diuresis volume in this population, particularly when accounting for confounding variables such as body composition. This study aimed to explore the possible relationship between inflammatory parameters and residual diuresis volume in patients on hemodialysis.
Methods
Blood samples were collected from patients on hemodialysis for the analysis of soluble receptors: 1) tumor necrosis factor receptor 1 (sTNFR1), 2) tumor necrosis factor receptor 2 (sTNFR2), and 3) leptin. Confounding variables, such as gender, age, duration of hemodialysis, Kt/V (a measure of dialysis adequacy), and body composition assessed using the dual-energy X-ray absorptiometry (DXA), were also evaluated. Data analyses were conducted using both single and multiple regression models, adjusted for the confounding parameters.
Results
Of the total sixty participants, 27 (45%) were classified as anuric, and 33 (55%) as non-anuric. High sTNFR1 plasma levels were associated with a lower residual diuresis volume, irrespective of adjustments for confounding parameters (R² = 25.4%; β = 0.504; p < 0.001).
Conclusion
This study supports the hypothesis that higher systemic levels of sTNFR1 may deteriorate residual renal function, as evidenced by the lower residual diuresis volume observed in patients on hemodialysis. These findings suggest that interventions aimed at reducing systemic inflammation may be beneficial in preserving residual renal function and improving clinical outcomes in these patients. Chronic Kidney Disease (CKD) is characterized by any persistent alteration or abnormality in kidney structure or function lasting over ninety days [1]. CKD’s subtle onset complicates diagnosis, and once established, it often progresses irreversibly [2]. Recognized globally as a major public health issue [3], CKD affects 10–13% of adults in economically advanced countries [1]. In Brazil, CKD poses significant healthcare challenges, causing over 35,000 deaths annually and incurring substantial treatment costs [4]. Projections indicate around 10 million CKD cases in Brazil, with about 90,000 individuals requiring dialysis [5,6]. This data underscores the urgent need to address CKD as a critical health challenge and develop comprehensive strategies to mitigate its impact on public health and healthcare costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro Integrado de Pós-Graduação e Pesquisa em Saúde (CIPq-Saúde), Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
- Laboratório de Fisiologia do Exercício - LAFIEX - CIPq/Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
- Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
- Programa de Pós-Graduação em Reabilitação e Desempenho Funcional, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
- Laboratório de Inflamação e Metabolismo - LIM - CIPq/Saúde, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
- Programa de Pós-Graduação Multicêntrico em Ciências Fisiológicas, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil.
ORCID-Profile: Mario Bernardo-Filho, Henrique Silveira, Ana Cristina Rodrigues Lacerda
Zitieren
APA
Gonçalves, G. T., Santos, L. M. M., Figueiredo, P. H. S., Freitas, J. P. C., Santos, J. M., Santos, J. N. V., Junior, F. A. D. S., Alves, F. L., Brandão, V. G., Maciel, E. H. B., Prates, M. C. S. M., Sañudo, B., Taiar, R., Bernardo-Filho, M., Sá-Caputo, D. D. C., Lima, V. P., Silveira, H., Gripp, V. L., Mendonça, V. A., & Lacerda, A. C. R. (2025). High level of soluble tumor necrosis factor receptors is associated with lower residual diuresis volume in patients on hemodialysis: An exploratory study. PLOS One. https://doi.org/10.1371/journal.pone.0320019
Vancouver
Gonçalves GT, Santos LMM, Figueiredo PHS, Freitas JPC, Santos JM, Santos JNV, et al. High level of soluble tumor necrosis factor receptors is associated with lower residual diuresis volume in patients on hemodialysis: An exploratory study. PLOS One. 2025. doi:10.1371/journal.pone.0320019
BibTeX
@article{Gonalves2025,
author = {Gonçalves, Gabriele Teixeira and Santos, Luciana Martins de Mello and Figueiredo, Pedro Henrique Scheidt and Freitas, Jaqueline de Paula Chaves and Santos, Jousielle Márcia and Santos, Joyce Noelly Vitor and Junior, Fidelis Antônio da Silva and Alves, Frederico Lopes and Brandão, Vanessa Gomes and Maciel, Emílio Henrique Barroso and Prates, Maria Cecília S M and Sañudo, Borja and Taiar, Redha and Bernardo-Filho, Mario and Sá-Caputo, Danúbia da Cunha de and Lima, Vanessa Pereira and Silveira, Henrique and Gripp, Victor Lacerda and Mendonça, Vanessa Amaral and Lacerda, Ana Cristina Rodrigues},
title = {High level of soluble tumor necrosis factor receptors is associated with lower residual diuresis volume in patients on hemodialysis: An exploratory study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0320019}
}
EUVIMED